| Website | dow.com/venture |
| Phone | (989) 636-1846 |
| Employees |
Dow Venture Capital (VC) has invested over $350 million in businesses based on Life Sciences & Biotechnology; Communications & Information Technology; and Physical Sciences. They invest, in part, through institutional venture capital firms, and also directly in start-up companies. They have developed a broad network of VC partners that specialize in their targeted investment markets and geographies. Dow VC’s investment professionals are widely experienced in discovering new investment opportunities, and supporting portfolio companies.
Typically, Dow VC takes active minority positions in syndicated investments, within the following guidelines:
Minimum investment: $250,000
Preferred investment: $500,000 to $5,000,000
Geographies: US, Canada, Europe, Japan
Part of their investment strategy is to support portfolio companies with access to Dow’s R&D and manufacturing organizations for technology development, act as a market defining customer of IT or other products, bring the significant brand equity and validation of a Fortune 50 company. Resources like these can be vital to a young company’s progress.
| Company | Date | Round | Size | Participants |
| Primet Precision Materials | 7/11 | Venture Round | 1 | |
| Xtreme Power | 7/10 | Series C | $29.5M | 3 |
| Clean Filtration Technology | 6/10 | Venture Round | $2M | 1 |
| Pfenex | 12/09 | Series A | $24M | 2 |
| Water Health International | 1/09 | Series D | $10M | 2 |
| Biolex Therapeutics | 10/08 | Series D | $60M | 12 |
| Biolex Therapeutics | 5/07 | Series C | $30M | 9 |
| Aveso | 10/06 | Series B | $6.25M | 3 |
| SiConnect | 9/06 | Series B | $5.32M | 4 |
| ZBD Displays | 8/06 | Venture Round | $5.43M | 5 |
| inSilica | 7/06 | Venture Round | $18M | 5 |
| Sionex | 12/05 | Series C | $12M | 4 |
| ZBD Displays | 10/05 | Venture Round | $4.7M | 5 |
| SiConnect | 5/05 | Series A | $4.9M | 4 |
| Cymbet | 12/04 | Series B | $16.5M | 4 |
